Back to List View Graph View

Ovarian cancer

Ovarian cancer is a malignant neoplasm arising in the ovary, fallopian tube, or peritoneum, and the most lethal gynecologic Cancer in high-income countries; worldwide, cervical Cancer causes more deaths.

Where the papers sit

11 papers from the last 6 months study ovarian cancer directly · updated from PubMed 15 Nov 2026

Study type 0 clinical trials · 4 observational · 3 human data · 3 preclinical · 1 unclassified

Themes no clear themes · 1 new direction

Those 11 do not share a common subject.

  • The topics range from ovarian cancer diagnosis and treatment to gynecologic cancer services, immune-cell biology, and haemophilic arthropathy. They share biomedical and clinical investigation but no unifying disease, mechanism, or endpoint. Individual studies address cfDNA fragmentomics, serum biomarkers, molecular profiling, radionuclide therapy, platinum complexes, hydrogels, and healthcare impacts. No coherent research direction or common therapeutic trend emerges from the group.

    11 papers

NEW DIRECTION

Ovarian cancer becomes a culturally situated health-knowledge and research-priority problem

The Pacific women’s knowledge and perceptions study treats ovarian cancer not as a tumour to diagnose, profile, model, or treat, but as a subject of community-defined understanding, prevention, early detection, quality-of-life priorities, and culturally preferred care. It found poor recognition of ovarian-cancer symptoms and treatments, alongside interest in traditional healers and alternative practitioners, shifting the direction toward culturally co-designed communication and research priorities rather than another biomedical intervention or disease model 42462231Jul.

Papers

The 11 papers from the last 6 months that study ovarian cancer directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

No clear themes (11)
  1. Preoperative discrimination of malignant and benign ovarian masses using cfDNA fragmentomics and serum biomarkers. Molecular biomedicine · 9 Nov 2026 PMID 43002351
  2. Is the preoperative routine blood test workable to distinguish early-stage from advanced-stage ovarian cancer? Taiwanese journal of obstetrics & gynecology · 28 Oct 2026 PMID 42951464
  3. Molecular profiling of ovarian cancer is feasible and provides valuable therapeutic and research information to women in Aotearoa New Zealand. The New Zealand medical journal · 23 Oct 2026 PMID 42912973
  4. Impact of the COVID-19 pandemic on diagnosis, treatment, and prognosis of cervical, endometrial, and ovarian cancers: A retrospective cohort study based on the SEER database. Medicine · 17 Oct 2026 PMID 42888541
  5. A 177Lu-Labeled Circular Bivalent Aptamer for PTK7-Targeting Radionuclide Therapy in Ovarian Cancer and Orthotopic Hepatoblastoma. Journal of medicinal chemistry · 10 Sept 2026 PMID 42720498
  6. Expanding the scope of platinum-NHC complexes: trans-Pt(II) and Pt(0) architectures for ovarian cancer treatment. Dalton transactions (Cambridge, England : 2003) · 20 Aug 2026 PMID 42622541
  7. Knowledge and perceptions of gynaecological cancers of Pacific women in Aotearoa New Zealand. The New Zealand medical journal · 16 Jul 2026 PMID 42462231
  8. Syringeable hyaluronic acid-based hydrogel co-loaded with cisplatin and MSA-2 for enhanced ovarian cancer chemoimmunotherapy. Biomedical materials (Bristol, England) · 15 Jul 2026 PMID 42456758
  9. Clonal lineage tracing of innate immune cells in human cancer. Cancer cell · 4 Jun 2026 PMID 42242233
  10. Multi-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach. PloS one · 1 Jun 2026 PMID 42224282
  11. The biomarkers uCTX-II, CS846 and IGF-1 are associated with clinical and ultrasound scores in haemophilic arthropathy: a cross-sectional study. Rheumatology international · 30 May 2026 PMID 42217051

By study type

Observational studies and case reports (4)
  1. Is the preoperative routine blood test workable to distinguish early-stage from advanced-stage ovarian cancer? Taiwanese journal of obstetrics & gynecology · 28 Oct 2026 PMID 42951464
  2. Impact of the COVID-19 pandemic on diagnosis, treatment, and prognosis of cervical, endometrial, and ovarian cancers: A retrospective cohort study based on the SEER database. Medicine · 17 Oct 2026 PMID 42888541
  3. Knowledge and perceptions of gynaecological cancers of Pacific women in Aotearoa New Zealand. The New Zealand medical journal · 16 Jul 2026 PMID 42462231
  4. The biomarkers uCTX-II, CS846 and IGF-1 are associated with clinical and ultrasound scores in haemophilic arthropathy: a cross-sectional study. Rheumatology international · 30 May 2026 PMID 42217051
Human data, design not indexed (3)
  1. Preoperative discrimination of malignant and benign ovarian masses using cfDNA fragmentomics and serum biomarkers. Molecular biomedicine · 9 Nov 2026 PMID 43002351
  2. Molecular profiling of ovarian cancer is feasible and provides valuable therapeutic and research information to women in Aotearoa New Zealand. The New Zealand medical journal · 23 Oct 2026 PMID 42912973
  3. Multi-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach. PloS one · 1 Jun 2026 PMID 42224282
Preclinical: animal, cell and lab studies (3)
  1. A 177Lu-Labeled Circular Bivalent Aptamer for PTK7-Targeting Radionuclide Therapy in Ovarian Cancer and Orthotopic Hepatoblastoma. Journal of medicinal chemistry · 10 Sept 2026 PMID 42720498
  2. Expanding the scope of platinum-NHC complexes: trans-Pt(II) and Pt(0) architectures for ovarian cancer treatment. Dalton transactions (Cambridge, England : 2003) · 20 Aug 2026 PMID 42622541
  3. Syringeable hyaluronic acid-based hydrogel co-loaded with cisplatin and MSA-2 for enhanced ovarian cancer chemoimmunotherapy. Biomedical materials (Bristol, England) · 15 Jul 2026 PMID 42456758
Unclassified: not yet indexed with MeSH (1)
  1. Clonal lineage tracing of innate immune cells in human cancer. Cancer cell · 4 Jun 2026 PMID 42242233